ROYAL BANK OF CANADA - BIONDVAX PHARMACEUTICALS LTD ownership

Back to all holdings Add to watchlist

BIONDVAX PHARMACEUTICALS LTD's ticker is and the CUSIP is 09073Q204.

Links
Filings
Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$0–40.0%0.00%–
Q2 2023$0–40.0%0.00%–
Q1 2023$0
-100.0%
4
-98.4%
0.00%–
Q4 2022$1,000–254–0.00%–
 Download
Other shareholders
BIONDVAX PHARMACEUTICALS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 190,927$269,2070.22%
NewSquare Capital LLC 2$30.00%
UBS Group AG 306$4310.00%
RHUMBLINE ADVISERS 3,499$4,7590.00%
CREDIT AGRICOLE S A 424$5980.00%
WELLS FARGO & COMPANY/MN 20$280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 11,578$15,7460.00%
MORGAN STANLEY 2,182$3,0770.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,921$14,8530.00%
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders